4 completed, 1 terminated. 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 2 |
Follow Daniel Benjamin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Modulators for Treating COVID-19 Infliximab, Abatacept, Remdesivir - Covid19 | Phase 3 | Completed | Daniel Benjamin | 1971 | 2020-10-15 | 2023-09-25 |
| Pharmacokinetics and Safety of Ertapenem in the Postpartum Period Ertapenem - Endometritis | Phase 1 | Terminated | Daniel Benjamin | 3 | 2012-03-01 | 2015-05-20 |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia | Completed | Daniel Benjamin | 3520 | 2011-11-01 | 2023-09-06 | |
| Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight fluconazole, placebo - Candidiasis | Phase 3 | Completed | Daniel Benjamin | 362 | 2008-11-01 | 2019-03-01 |
| Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers Fluconazole Loading Dose, Fluconazole Loading Dose & High Dose - Candidiasis | Phase 1 | Completed | Daniel Benjamin | 13 | 2008-11-01 | 2018-11-05 |
Candidiasis (2) · Sepsis (2) · Adenoviridae Infections (1) · Anxiety Disorders (1) · Arrhythmias, Cardiac (1) · Autistic Disorder (1) · Bipolar Disorder (1) · Bradycardia (1) · COVID-19 (1) · Candidemia (1) · Central Nervous System Infections (1) · Cytomegalovirus Retinitis (1) · Endocarditis (1) · Endometritis (1) · Epilepsy (1)
Fluconazole (2) · Abatacept (1) · Alfentanil (1) · Amikacin (1) · Aminocaproic Acid (1) · Bosentan (1) · Cefepime (1) · Cidofovir (1) · Ciprofloxacin (1) · Clozapine (1) · Ertapenem (1) · Fosfomycin (1) · Haloperidol (1) · Infliximab (1) · Labetalol (1)
United States (5) · Argentina (1) · Brazil (1) · Canada (1) · Israel (1) · Mexico (1) · Peru (1) · Singapore (1) · United Kingdom (1)
Bill Powderly, MD (1) · Chi Hornik, PharmD (1) · Daniel K Benjamin, MD MPH PhD (1) · Daniel K Benjamin, MD, PhD (1) · Geeta Swamy, MD (1)
PMID 19915602, PMID 24614374, PMID 24794367, PMID 24949994, PMID 26039810, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28779462, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30790601, PMID 31317556, PMID 31548185, PMID 31814149, PMID 32324313, PMID 32497307, PMID 33029806, PMID 33903114, PMID 34302290, PMID 34473343, PMID 35370711, PMID 35491971, PMID 36172138, PMID 36203544, PMID 37428480, PMID 38662372, PMID 39610848, PMID 41247430
R01HD057956 (1)